image
Healthcare - Medical - Care Facilities - NYSE - CN
$ 5.0
-1.54 %
$ 23.3 M
Market Cap
-0.45
P/E
1. INTRINSIC VALUE

Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel.[ Read More ]

The intrinsic value of one CCM stock under the base case scenario is HIDDEN Compared to the current market price of 5 USD, Concord Medical Services Holdings Limited is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CCM

image
FINANCIALS
537 M REVENUE
13.84%
-463 M OPERATING INCOME
11.82%
-531 M NET INCOME
30.95%
-276 M OPERATING CASH FLOW
-27.59%
-47.7 M INVESTING CASH FLOW
59.86%
258 M FINANCING CASH FLOW
-32.74%
30.3 M REVENUE
-13.21%
-27.4 M OPERATING INCOME
20.33%
-13.1 M NET INCOME
75.56%
16 M OPERATING CASH FLOW
102.12%
0 INVESTING CASH FLOW
0.00%
0 FINANCING CASH FLOW
100.00%
Balance Sheet Decomposition Concord Medical Services Holdings Limited
image
Current Assets 617 M
Cash & Short-Term Investments 58.1 M
Receivables 73.5 M
Other Current Assets 486 M
Non-Current Assets 5.44 B
Long-Term Investments 395 M
PP&E 4.13 B
Other Non-Current Assets 915 M
Current Liabilities 1.95 B
Accounts Payable 129 M
Short-Term Debt 1.09 B
Other Current Liabilities 733 M
Non-Current Liabilities 2.36 B
Long-Term Debt 2.21 B
Other Non-Current Liabilities 149 M
EFFICIENCY
Earnings Waterfall Concord Medical Services Holdings Limited
image
Revenue 537 M
Cost Of Revenue 614 M
Gross Profit -76.6 M
Operating Expenses 386 M
Operating Income -463 M
Other Expenses 68 M
Net Income -531 M
RATIOS
-14.26% GROSS MARGIN
-14.26%
-86.15% OPERATING MARGIN
-86.15%
-55.39% NET MARGIN
-55.39%
14.03% ROE
14.03%
-4.92% ROA
-4.92%
-47.36% ROIC
-47.36%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Concord Medical Services Holdings Limited
image
Net Income -531 M
Depreciation & Amortization 128 M
Capital Expenditures -120 M
Stock-Based Compensation 0
Change in Working Capital -55 M
Others 42.4 M
Free Cash Flow -396 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Concord Medical Services Holdings Limited
image
CCM has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0.99 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Concord Medical Services Holdings Limited
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
7. News
Concord Medical Schedules 2024 Annual Meeting of Shareholders BEIJING , Nov. 13, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it will hold its 2024 annual general meeting of shareholders (the "Meeting") on December 27, 2024, at 10:00 a.m. (Beijing Time). prnewswire.com - 3 days ago
Concord Medical Reports Financial Results for the First Half of 2024 BEIJING , Sept. 27, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2024 [1]. prnewswire.com - 1 month ago
Canagold Completes Resource Expansion Drilling Program at New Polaris with Additional Strong Mineralization Intercepts VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM #drilling--Canagold Resources Ltd. (“Canagold” or the “Company”) (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) announces sample assay results from an additional 2 drill holes from the resource expansion drill program targeting the North Zone at its 100% owned New Polaris Gold project located in northwestern British Columbia, 100 kilometers (km) south of Atlin and 60 km northeast of Juneau, Alaska. Details of the holes are shown in Table 1. Highlights 10.8 grams p. businesswire.com - 1 month ago
Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment BEIJING , Sept. 16, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that Guangzhou Concord Cancer Center ("Guangzhou Hospital"), a PRC subsidiary of the Company offering comprehensive cancer care services, has obtained the large medical equipment procurement license (the "License") for its proton equipment. prnewswire.com - 2 months ago
Concord Medical Regains Compliance with NYSE Minimum Price Requirement BEIJING , Aug. 7, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it has received a letter from the New York Stock Exchange ("NYSE") dated August 6, 2024 (the "Compliance Notice"), notifying the Company that it is no longer considered below the NYSE's continued listing criterion of a minimum average share price of US$1.00 over a 30 trading-day period (the "NYSE Minimum Price Requirement"). As previously announced, the Company received a letter from the NYSE dated February 12, 2024, notifying the Company that it was below compliance standards due to the trading price of its American Depositary Shares. prnewswire.com - 3 months ago
CONCORD MEDICAL ANNOUNCES PLAN TO IMPLEMENT ADS RATIO CHANGE BEIJING , July 11, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it plans to change the ratio of its American depositary shares ("ADSs") to Class A ordinary shares (the "ADS Ratio") from the current ADS Ratio of one (1) ADS representing three (3) Class A ordinary shares to a new ADS Ratio of one (1) ADS representing thirty (30) Class A ordinary shares. The Company anticipates that the change in the ADS Ratio will be effective on July 30, 2024 (U.S. Eastern Time). prnewswire.com - 4 months ago
Canagold Resources Ltd. Announces Voting Results From Annual General Meeting VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (the “Company”) announces that at its annual general meeting of shareholders held on June 12, 2024 (the “Meeting”), all directors listed in the Information Circular dated May 9, 2024 were elected. The detailed results are as follows: Nominee Director Votes For % Votes For Votes Withheld % Votes Withheld Sofia Bianchi 93,941,380 99.46 511,258 0.54 Kadri Dagdelen 94,112,959 99.64 339,6. businesswire.com - 5 months ago
Canagold Initiates Resource Expansion Drilling at New Polaris Project VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (the “Company” or “Canagold”), is pleased to announce that, in line with its commitment to accelerating the advancement of the New Polaris Gold project towards production, drill crews have been mobilized to the site in northern British Columbia to restart drilling operations. The 2024 drilling program includes 12,000 meters of drilling, primarily targeting high-grade mineralization a. businesswire.com - 5 months ago
Concord Medical Files 2023 Annual Report on Form 20-F BEIJING , April 19, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov. prnewswire.com - 6 months ago
Canagold Resources Ltd. Announces Closing of $4.1M Charity Flow Through Financing VANCOUVER, British Columbia--(BUSINESS WIRE)---- $CCM.T #drilling--Canagold Resources Ltd. (TSX: CCM, OTC-QB: CRCUF, Frankfurt: CANA) (the "Company" or "Canagold"), is pleased to announce it has closed a charity flow-through financing with Sun Valley Investments AG (“Sun Valley”). The Company issued 15,700,000 common shares of the Company (the “FT Share”) that qualify as flow-through shares for the purposes of the Income Tax Act (Canada) at a price of $0.2625 per FT Share for total gross proceeds of $4,121,500 (the. businesswire.com - 7 months ago
Concord Medical Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price BEIJING , Feb. 20, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it has received a letter (the "Letter") from the New York Stock Exchange (the "NYSE") dated February 12, 2024, notifying the Company that it is below compliance standards due to the trading price of the Company's American depositary shares (the "ADSs") and that the applicable cure period for the Company to regain compliance expires on August 12, 2024. Pursuant to applicable NYSE continued listing standards, a company would be considered "below criteria" by the NYSE if the average closing price of a security as reported on the consolidated tape is less than $1.00 over a consecutive 30 trading-day period. prnewswire.com - 8 months ago
Concord Medical Announces Listing of Its Subsidiary on The Stock Exchange of Hong Kong Limited BEIJING , Jan. 9, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced the listing of a minority stake of 39,420,200 H shares in Concord Healthcare Group Co., Ltd. ("Concord Healthcare"), its subsidiary, at an initial public offer price of HK$14.28 per H share on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the stock code 2453.HK. prnewswire.com - 10 months ago
8. Profile Summary

Concord Medical Services Holdings Limited CCM

image
COUNTRY CN
INDUSTRY Medical - Care Facilities
MARKET CAP $ 23.3 M
Dividend Yield 0.00%
Description Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Contact Tower A, Global Trade Center, Beijing, 100013 https://www.concordmedical.com
IPO Date Dec. 11, 2009
Employees 727
Officers Ms. Xun Liu Financial Controller Mr. Boxun Zhang Chief Financial Officer Dr. Jianyu Yang Chairman & Chief Executive Officer